Results 231 to 240 of about 250,267 (258)
Some of the next articles are maybe not open access.
Multiple Myeloma Minimal Residual Disease
2016Assessment of minimal residual disease (MRD) is becoming standard diagnostic care for potentially curable neoplasms such as some acute leukemias as well as chronic myeloid and lymphocytic leukemia. Although multiple myeloma (MM) remains as an incurable disease, around half of the patients achieve complete remission (CR), and recent data suggests ...
Bruno, Paiva +2 more
openaire +2 more sources
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?
Hematology/Oncology Clinics of North America, 2021John F Seymour +2 more
exaly
Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
Cancers, 2021Jean-Pascal Machiels +2 more
exaly
Biomarkers of minimal residual disease and treatment
Minimal residual disease (MRD) has been defined as a very small numbers of cancer cells that remain in the body after curative treatment. Its presence or absence will ultimately determine prognosis. With the introduction of new technologies the presence of MRD in patients with solid tumours can be detected and characterized.openaire +2 more sources
Minimal residual disease in cancer therapy – Small things make all the difference
Drug Resistance Updates, 2015Sven Rottenberg, Sohvi Blatter
exaly